Edgewell Personal Care (EPC) Form 3 EDGEWELL PERSONAL CARE / FRANCESCA WEISSMAN ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

WEISSMAN FRANCESCA

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/01/2024

3. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	24,565	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non Qualified Stock Option 11/14/2019	(1)	11/14/2029	Common Stock	6,431	31.44	D
Non Qualified Premium Stock Option 11/13/2020	(1)	11/13/2030	Common Stock	5,476	38.91	D
Non Qualified Stock Option 11/13/2020	(1)	11/13/2030	Common Stock	2,617	35.37	D
Non Qualified Stock Option 11/12/2021	(1)	11/12/2031	Common Stock	4,450	43.29	D
Non Qualified Stock Option 11/11/2022	(2)	11/11/2032	Common Stock	4,074	39.75	D
Non Qualified Stock Option 11/10/2023	(3)	11/10/2033	Common Stock	5,193	34.22	D
Restricted Stock Equivalent 11/11/2022	11/11/2025	11/11/2025	Common Stock	780	0	D
Restricted Stock Equivalent 11/10/2023	(4)	(4)	Common Stock	2,046	0	D
Performance Restricted Stock Equivalent 11/11/2022	11/14/2025	11/14/2025	Common Stock	3,900	0	D
Performance Restricted Stock Equivalent 11/10/2023	11/11/2026	11/11/2026	Common Stock	5,114	0	D

Explanation of Responses:

1. These options are fully vested and exercisable.

2. 2,716 of these options are vested and exercisable with the remaining 1,358 vesting on 11/11/2025.

3. 1,731 of these options are vested and exercisable with the remaining 3,462 vesting ratably on 11/10/2025 and 11/10/2026.

4. 1,023 shares each will vest on 11/10/2025 and 11/10/2026.

	/s/ Francesca Weissman	12/03/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.